| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6022198 | Neurobiology of Disease | 2014 | 8 Pages |
Abstract
This example demonstrates how using data from the preclinical studies is possible to build decision points into an early clinical development plan that will allow early assessment of potential efficacy and allow timely go/no go decisions.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo, Matthew D. Surman,